文献速递骨肌MRUS

磁共振与超声在跟腱病中的应用:对富白细胞血小板血浆和脂肪源性基质血管组分注射的预测作用与反应评估

Magnetic resonance and ultrasound in achilles tendinopathy: Predictive role and response assessment to platelet-rich plasma and adipose-derived stromal vascular fraction injection.
PubMed 文献 · Eur J Radiol · 2017-08-09

43例非止点性跟腱病患者(58条跟腱)随机接受富白细胞血小板血浆或脂肪源性基质血管组分腱内注射,基线及6个月时行MRI、超声和VAS疼痛评估;两种治疗似乎均带来临床获益,伴腱尺寸和能量多普勒信号早期轻度增加,但治疗前影像参数均不能预测临床结局。

要点

  • MRI与超声测量跟腱厚度一致性极好(ICC=0.986)。
  • 治疗后6个月VAS疼痛从6.4±1.4降至1.8±1.7(P<0.001)。
  • 治疗前影像参数均不能预测临床结局(P>0.104)。

核心结论

  • 两种注射治疗似乎均带来临床获益,伴腱尺寸和能量多普勒信号早期轻度增加;影像不能用作临床结局的预测因素。

研究设计与样本

  • 随机对照研究,43例患者(年龄47.8±5.1岁,范围29-55)共58条非止点性跟腱病跟腱,随机分为富白细胞血小板血浆组(22例,28条跟腱)和脂肪源性基质血管组分组(21例,30条跟腱),基线及治疗后6个月行MRI、超声和VAS疼痛评估。

关键影像表现/征象

  • MRI测量跟腱横截面积、信号强度和最大前后厚度,超声测量最大前后厚度、能量多普勒信号和灰阶回声纹理。
  • 治疗后MRI(P=0.013)和超声(P=0.012)测量的跟腱厚度及能量多普勒信号(P=0.027)显著增加。
  • 治疗前后横截面积、信号强度和回声纹理无显著差异(P>0.217)。

诊断标准与关键数值

  • MRI与超声测量跟腱厚度的组内相关系数=0.986,一致性极好。
  • 治疗前各项影像参数均不能预测治疗结局(P>0.104)。
  • VAS疼痛从治疗前6.4±1.4降至6个月评估时1.8±1.7(P<0.001)。

临床应用与阅片要点

  • MRI与超声测量跟腱厚度一致性极好,两者均可用于跟腱厚度评估。
  • 治疗后跟腱厚度和能量多普勒信号早期轻度增加,可伴随临床疼痛改善。
  • 治疗前影像参数不能预测临床结局,影像不用于筛选可能获益的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the correlation between magnetic resonance and ultrasound findings and clinical outcome after intratendinous injection of leucocyte-rich platelet-rich plasma or adipose-derived stromal vascular fraction in patients with non-insertional Achilles tendinopathy.

MATERIALS AND METHODS: Forty-three patients (age: 47.8±5.1, range 29-55) with unilateral or bilateral non-insertional Achilles tendinopathy (58 tendons overall) were randomly assigned to platelet-rich plasma (22 patients, 28 tendons) or adipose-derived stromal vascular fraction (21 patients, 30 tendons) injection group. All patients underwent magnetic resonance (tendon cross-sectional area, signal intensity, maximum anteroposterior thickness were measured), ultrasound (maximum anteroposterior thickness, power Doppler signal, ultrasound gray scale echotexture were measured), and visual analogue scale (VAS) pain evaluation at baseline and at six months from treatment. Wilcoxon, intraclass correlation coefficient, repeated measure ANOVA tests were used.

RESULTS: There was a significant (P<0.001) decrease of mean VAS from pre-treatment (6.4±1.4) to six-month evaluation (1.8±1.7). Significant increase of tendon thickness measured using magnetic resonance (P=0.013) and ultrasound (P=0.012) and power Doppler signal (P=0.027) was seen. There was no significant difference between pre- and post-treatment cross sectional area, signal intensity, and echotexture (P>0.217). None of the pre-treatment parameters was a predictor of treatment outcome (P>0.104). There was an excellent agreement between tendon thickness measurement between magnetic resonance and ultrasound (intraclass correlation coefficient=0.986) CONCLUSIONS: Both treatments seem to allow for clinical benefit, associated to early slight increase of tendon size and power Doppler signal. Imaging cannot be used as a predictor of clinical outcome.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Albano D, Messina C, Usuelli FG, et al. Magnetic resonance and ultrasound in achilles tendinopathy: Predictive role and response assessment to platelet-rich plasma and adipose-derived stromal vascular fraction injection. Eur J Radiol. 2017. PMID: 28987658. doi:10.1016/j.ejrad.2017.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。